To investigate the expression of type 3 deiodinase (Dio3) in non-neuronal cell types within brain barrier tissues during embryonic and neonatal development in mice.
Key Findings:
Rephrase to avoid suggesting roles unless explicitly stated in the source.
Interpretation:
Remove unsupported claims and rephrase to reflect only what is stated in the source.
Limitations:
The study primarily focuses on embryonic and neonatal stages, limiting insights into later developmental stages.
Detection of Dio3 expression in non-neuronal cell types may not fully capture its functional implications.
Conclusion:
Rephrase to avoid unsupported claims about the significance of Dio3.
Teriparatide followed by zoledronic acid increased bone mineral density but did not reduce fracture risk compared with standard care in adults with osteogenesis imperfecta.
